SEC 13F Intelligence

Ghost Tree Capital, LLC / CTIC1USD

Ghost Tree Capital, LLC’s Cti Biopharma Corp Position

Does Ghost Tree Capital, LLC own Cti Biopharma Corp (CTIC1USD)? Not currently — the last reported position was 2.00M shares worth $8M in Q1 2023; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$8M
Q1 2023
Shares
2.00M
% of Portfolio
+2.48%
Quarters Held
10
position exited

Position History CTIC1USD

Reported value by quarter
Q4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $4MQ2 ’21Q3 ’21: $5MQ4 ’21: $3MQ4 ’21Q1 ’22: $6MQ2 ’22: $5MQ2 ’22Q3 ’22: $12MQ4 ’22: $11MQ4 ’22Q1 ’23: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20232.00M$8M+2.48%
Q4 20221.85M$11M+4.75%
Q3 20222.00M$12M+3.27%
Q2 2022800.0K$5M+2.49%
Q1 20221.30M$6M+1.32%
Q4 20211.20M$3M+1.07%
Q3 20211.60M$5M+1.38%
Q2 20211.60M$4M+1.10%
Q1 2021750.0K$2M+0.51%
Q4 2020750.0K$2M+0.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of CTIC1USD.